Published: 17-11-2026 10:30 | Updated: 17-11-2026 10:30

Kerstin Brismar Award 2026 to Per-Ola Carlsson

Kerstin Brismar and Per-Ola Carlsson
Kerstin Brismar and Per-Ola Carlsson Photo: Stefan Zimmerman

Prof. Per-Ola Carlsson, from Uppsala University, receives the 2026 Kerstin Brismar Award for his contribution to translational diabetes research. The ceremony took place on November 10.

At Nobel Forum on November 10, Professor Per-Ola Carlsson, of Uppsala University Hospital and Uppsala University received the Kerstin Brismar Award consisting of a diploma and a grant of half a million Swedish kronor. Carlsson, receives it for his translational research (i.e. research where results from basic research are transferred to patient-oriented clinical research).  

The decision to nominate Per-Ola Carlsson was unanimous among the members of the scientific committee for the Kerstin Brismar Award. The committee justifies the decision by stating: “Undisputedly the most significant development in the field of type 1 diabetes research field ‘Cure’ since the first islet transplantations were performed many years ago.”
- I am incredibly honored to receive this award! The grant is an important contribution to our work to transform type 1 diabetes from a chronic disease into a curable one,” says Per-Ola Carlsson.

 In connection with the award ceremony Per-Ola Carlsson delivered the prize lecture “Will Diabetes type-1 be cured?”. 

Per-Ola Carlsson, is the first in the world to transplant insulin-producing cells, pre-treated to avoid rejection, into a patient with intractable type 1 diabetes. The results are very promising: for over a year, the cells have continued to produce insulin in unchanged amounts without the patient needing immunosuppressive drugs. The cells come from human donors.
The groundbreaking thing is that a method developed in the laboratory by Professor Sonja Schrepfer, USA, has now been tested clinically. By pre-treating the insulin-producing cells, rejection and destruction of the cells can be prevented – a clear example of how translational research can bring the laboratory's discoveries closer to patients.
Now the research is moving on to the next phase. The goal is to grow stem cells in unlimited quantities in the laboratory and pre-treat them in the same way. If the method is successful, more patients in the future may have access to new and better treatments, and in the long term a cure for type 1 diabetes.

Results from last year’s grant, a part of Kerstin Brismar Award 2025
In connection to the ceremony senior lecturer and paediatrician Pär Andersson White presented research supported by grants, a part of Kerstin Brismar Award 2025. He works with Professor Johnny Ludvigsson at Linköping University, founder of the Swedish Child Diabetes Foundation and recipient of Kerstin Brismar Award 2025. They are investigating whether an older heart medication can help young children recently diagnosed with type 1 diabetes preserve as many of their remaining insulin-producing cells as possible for a longer time, thereby improving their quality of life for several years.

The Kerstin Brismar Award was established in 2025 and is named after Senior Professor Kerstin Brismar in diabetes research at Karolinska Institutet, and a co-founder of the Rolf Lufts Foundation for Diabetes Research. The initiators of the award are Marika Treschow and Eva Josephson. 

The Kerstin Brismar Award is presented for the second time. The prize and research grant have been made possible through private donations.